Using Mendelian randomization study to assess the renal effects of antihypertensive drugs

BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and/or in combination with calcium channel blockers (CCBs) are generally recommended as the first-line antihypertensive therapy for people with hypertension and kidney dysfunction. Evidence from large randomized controlled trials comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie V., Schooling, C. Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995783/
https://www.ncbi.nlm.nih.gov/pubmed/33766008
http://dx.doi.org/10.1186/s12916-021-01951-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995783/
https://www.ncbi.nlm.nih.gov/pubmed/33766008
http://dx.doi.org/10.1186/s12916-021-01951-4

Ejemplares similares